Search
Rheumatoid Arthritis Clinical Trials in Worcester, MA
A listing of 1 Rheumatoid Arthritis clinical trials in Worcester, MA actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
The city of Worcester, Massachusetts, currently has 1 active clinical trials seeking participants for Rheumatoid Arthritis research studies.
Featured Trial
Cardiovascular Disease Trials
Recruiting
Cardiovascular Disease trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Cardiovascular Disease
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Healthy Volunteer Trials
Recruiting
Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Healthy
Featured Trial
Interested in vaccine studies Trials
Recruiting
Interested in vaccine studies trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Interested in vaccine studies
Healthy
Healthy Volunteers
Featured Trial
Overweight Trials
Recruiting
Overweight trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Overweight
Overweight and Obesity
Overweight or Obesity
Obesity and Overweight
Obesity
Featured Trial
Low back pain Trials
Recruiting
Low back pain trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Low back pain
RA-PRO PRAGMATIC TRIAL
Recruiting
The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (tsDMARD; choose among existing medications, currently, tofacitinib, baricitinib, upadacitinib) in patients with active RA despite the use of a TNFi-biologic. In practice, most patients receive another... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/04/2024
Locations: University of Massachusetts Chan Medical School, Worcester, Massachusetts
Conditions: Rheumatoid Arthritis
1 - 1 of 1